Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16 Melanoma 8 Lung Neoplasms 8 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Solid Tumours 5 Neoplasms 5 Breast Neoplasms 4 Uveal Melanoma 3 Thyroid Neoplasms 3 Pancreatic Neoplasms 3 Neurofibromatosis 1 3 Colonic Neoplasms 3 Thyroid Cancer, Papillary 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Adult Solid Neoplasm 2 Thyroid Diseases 1 Thymoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Optic Nerve Glioma 1 Non-small Cell Lung Cancer Metastatic 1 Neurofibrosarcoma 1 Neurofibroma, Plexiform 1 Neuroblastoma 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Nivolumab 13 Surveys and Questionnaires 6 Ipilimumab 6 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 Sirolimus 4 Pemetrexed 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 ARRY-334543 4 temsirolimus 3 relatlimab 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 regorafenib 2 anlotinib 2 abemaciclib 2 Vorinostat 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 Dasatinib 2 Cyclophosphamide 2 vorolanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Cancer × AZD 6244 × Clear all

NCT00085787 2020-10-14

A Study of ARRY-142886 in Patients With Advanced Cancer

Array BioPharma

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡